-
公开(公告)号:US20240316194A1
公开(公告)日:2024-09-26
申请号:US18574161
申请日:2022-06-29
Applicant: AMGEN INC.
IPC: A61K39/395 , A61K9/00 , A61K9/19 , A61K39/00 , A61K47/10 , A61K47/18 , A61K47/26 , C07K16/28 , C07K16/30
CPC classification number: A61K39/39591 , A61K9/0019 , A61K9/19 , A61K47/10 , A61K47/183 , A61K47/26 , C07K16/2809 , C07K16/3092 , A61K2039/505 , C07K2317/31 , C07K2317/94
Abstract: Described herein is a method comprising (a) reconstituting a lyophilized formulation comprising a polypeptide, a saccharide, a surfactant, and a buffer, with a diluent comprising an aromatic alcohol, a phenolic compound, or an amino acid with aromatic side chain, and (b) administering the reconstituted formulation to a subject in need thereof within 12 hours of reconstitution, wherein the polypeptide is a bispecific antibody construct, such as a bispecific antibody construct that binds human DLL3 and human CD3 and optionally comprises the amino acid sequence of SEQ ID NO: 75 and SEQ ID NO: 9.
-
公开(公告)号:US20240208680A1
公开(公告)日:2024-06-27
申请号:US18288549
申请日:2022-05-19
Applicant: AMGEN INC.
Inventor: Devrishi Goswami , Jun Zhang , Deirdre Piedmonte , Vikashni Padmakumar , David Le , Maria Raquel Santos , Wei Qi
Abstract: A method of filing a vial. The method includes providing a pump corresponding to a vial and setting a drip retraction parameter for the pump to any value equal to or less than 20 degrees. The method also includes setting a no adjustment limit for a fill weight of the vial to T1, with T1 being at or in a range of about 2% more or less than a fill weight of a target fill weight T0, wherein a process performance index Cpk (Cpk) for the vial throughout a fil cycle exceeds a minimum value.
-
公开(公告)号:US20220362104A1
公开(公告)日:2022-11-17
申请号:US17770355
申请日:2020-10-23
Applicant: AMGEN INC. , AMGEN RESEARCH MUNICH GMBH
Inventor: Cornelius Pompe , Nicholas J. Clark , Wei Qi , Arnold J. McAuley , MIchael Schneider , Chia-Jung Wu , Twinkle R. Christian , Heather N. Franey , Bharadwaj Jagannathan , Jeffrey Abel , Franz Dietzel
Abstract: An approach for determining material compatibility for components of a drug delivery system is provided that includes using surface zeta-potential analytical method to evaluate surface interactions between a desired molecule and at least one material present within a given IV-bag system.
-
-